| Time | Topics | Speaker/s |
|
16:30
-
16:50
|
The NFKB Pathway in Uveal Melanoma
|
Zahra Souri, PhD
|
|
16:50
-
17:10
|
Nanoparticle-Mediated Combination Therapy for Retinoblastoma Management
|
Elham Delrish, PhD
|
|
17:10
-
17:30
|
Emerging Treatment Options for Targeting Retinoblastoma
|
Mohammad reza Mehrabi Bahar, MD
|
